1,792 research outputs found
A comparison of magnetic resonance imaging and neuropsychological examination in the diagnostic distinction of Alzheimer’s disease and behavioral variant frontotemporal dementia
The clinical distinction between Alzheimer's disease (AD) and behavioral variant frontotemporal dementia (bvFTD) remains challenging and largely dependent on the experience of the clinician. This study investigates whether objective machine learning algorithms using supportive neuroimaging and neuropsychological clinical features can aid the distinction between both diseases. Retrospective neuroimaging and neuropsychological data of 166 participants (54 AD; 55 bvFTD; 57 healthy controls) was analyzed via a Naïve Bayes classification model. A subgroup of patients (n = 22) had pathologically-confirmed diagnoses. Results show that a combination of gray matter atrophy and neuropsychological features allowed a correct classification of 61.47% of cases at clinical presentation. More importantly, there was a clear dissociation between imaging and neuropsychological features, with the latter having the greater diagnostic accuracy (respectively 51.38 vs. 62.39%). These findings indicate that, at presentation, machine learning classification of bvFTD and AD is mostly based on cognitive and not imaging features. This clearly highlights the urgent need to develop better biomarkers for both diseases, but also emphasizes the value of machine learning in determining the predictive diagnostic features in neurodegeneration
Multimodal phenotyping of synaptic damage in Alzheimer’s disease : translational perspective with focus on quantitative EEG
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the most common
form of dementia. Accumulation of AD-associated pathology in the brain may begin a decade
or more before the appearance of the first symptoms of the disease. The pathological-clinical
“continuum of AD” therefore encompasses time between the initial neuropathological changes
and symptoms of advanced disease. Besides cognitively healthy individuals at risk, it includes
subjects with subjective cognitive decline (SCD), mild cognitive impairment (MCI) and
eventually dementia when the severity of cognitive impairment affects patients’ ability to carry
out everyday activities. Timely detection of the disease would therefore recognize patients that
are at risk for future cognitive deterioration and provide time window for the prevention and
novel therapeutical interventions. Accumulating evidence suggests that degeneration and
dysfunction of brain neuronal connections, i.e. synapses, is one of the earliest and best proxies
of cognitive deficits in patients along AD continuum. Human electroencephalography (EEG)
is a non-invasive and widely available diagnostic method that records real-time large-scale
synaptic activity. The commonly used method in research settings is quantitative EEG (qEEG)
analysis that provides objective information on EEG recorded at the level of the scalp.
Quantitative EEG analysis unravels complex EEG signal and adds relevant information on its
spectral components (frequency domain), temporal dynamics (time domain) and topographic
estimates (space domain) of brain cortical activity. The general aim of the present thesis was
to characterize different aspects of synaptic degeneration in AD, with the focus on qEEG and
its relationship to both conventional and novel synaptic markers. In study I, global qEEG
measures of power and synchronization were found to correlate with conventional
cerebrospinal fluid (CSF) biomarkers of Aβ and tau pathology in patients diagnosed with SCD,
MCI and AD, linking the markers of AD pathology to the generalized EEG slowing and
reduced brain connectivity in fast frequency bands. In study II, qEEG analysis in the time
domain (EEG microstates) revealed alterations in the organization and dynamics of large-scale
brain networks in memory clinic patients compared to healthy elderly controls. In study III,
topographical qEEG analysis of brain functional connectivity was associated with regionspecific
cortical glucose hypometabolism ([18F]Fluorodeoxyglucose positron-emission
tomography) in MCI and AD patients. Study IV provided evidence that qEEG measures of
global power and synchronization correlate with CSF levels of synaptic marker neurogranin,
both modalities being in combination independent predictors of progression to AD dementia
in MCI patients. Study V and associated preliminary study introduced in the thesis assessed the
translational potential of CSF neurogranin and qEEG as well as their direct relationship to AD
neuropathology in App knock-in mouse models of AD. In study V, changes in CSF neurogranin
levels and their relationship to conventional CSF markers in App knock-in mice corresponded
to the pattern observed in clinical AD cohorts. These findings highlighted the potential use of
mouse CSF biomarkers as well as App knock-in mouse models for translational investigation
of synaptic dysfunction due to AD. In general, the results of the thesis invite for further clinical
validation of multimodal synaptic markers in the context of early AD diagnosis, prognosis, and
treatment monitoring in individual patients
The Spatial Evolution of Tau Pathology in Alzheimer’s Disease: Influence of Functional Connectivity and Education
Alzheimer’s disease is neuropathologically characterized by extracellular accumulation of
amyloid beta plaques and intracellular aggregation of misfolded tau proteins, which eventually
lead to neurodegeneration and cognitive impairment. With the recent advances in
neuroimaging, these two proteinopathies can now be studied in vivo using positron emission
tomography (PET). Combining this imaging technique with functional magnetic resonance
imaging has consistently revealed a spatial overlap between amyloid beta accumulates and
functional connectivity networks (Buckner et al., 2009; Grothe et al., 2016), indicating
functional connectivity as mechanistic pathway in the distribution of neuropathologies. While
the infiltration of these neuronal networks by amyloid beta deposits seems uniform across
individuals with Alzheimer’s disease, there nevertheless exists inter-individual differences in
the clinical expression of the disease despite similar pathological burden (Stern, 2012). This
observation has fuelled the concept of existing resilience mechanisms, which are supported by
lifetime and –style factors and, which magnitude varies between individuals, contributing to
the clinical heterogeneity seen in Alzheimer’s disease.
Even though the spreading and resilience mechanisms in the phase of amyloid beta accumulation
are now better understood, no information on tau pathology in vivo were available in this regard
until recently. Given the recent introduction of tau PET compounds, this thesis therefore aimed
to address two questions: 1) whether functional connectivity contributes to the distribution of
tau pathology across brain networks, and 2) whether the consequence of tau pathology on
cognitive and neuronal function is mitigated by a resilience proxy, namely education. Using
[18F]-AV-1451 PET imaging to quantify tau pathology in a group of Alzheimer’s disease
patients, we observed that tau pathology arises synchronously in independent components of
the brain, which in turn moderately overlap with known functional connectivity networks. This
suggest that functional connectivity may act as contributing factor in the stereotypical
distribution of tau pathology. Moreover, the results of this thesis demonstrate that the
consequence of regional tau pathology on cognition differs depending on the level of education.
Despite equal clinical presentation, higher educated patients can tolerate more tau pathology,
already in regions related to advanced disease stage, than lower educated patients. Furthermore,
tau pathology is less paralleled by neuronal dysfunction at higher levels of education. Thus,
higher educated individuals show a relative preservation of neuronal function despite the
aggregation of misfolded tau proteins. This maintenance of neuronal function may in turn
explain the relative preservation of cognitive function albeit progressive tau pathology
aggregation.
Taken together, the results of this thesis provide novel insights into the spreading mechanisms
and the role of resilience factors towards tau pathology aggregation, which may not only be
relevant for Alzheimer’s disease, but other neurodegenerative diseases, in particular,tauopathies. Better understanding of the spreading mechanisms in these diseases will permit a
more precise prediction of disease progression and will thus be valuable for disease monitoring.
Concomitantly, the development of sensitive biomarkers for disease monitoring is crucial for
the evaluation of anti-tau-based therapies. Regarding the development of pharmacological
strategies, the current results also indicate that proxy measures of resilience, such as education,
need to be considered when allocating patients to treatment groups. Biased allocation may
otherwise lead to a misinterpretation of observed effects that are not due to the drug but the
group characteristics. Aside from this, sensitive tools for the early identification of at-risk
individuals with high resilience need to be established to allow for a timely intervention.
Current hypothesis is that an early intervention has the highest chance of success in modifying
the disease course. However, as demonstrated by this work, individuals with high resilience
remain undiagnosed until late in the disease course. Further research into resilience mechanisms
may thus support the development of sensitive diagnostic tools and additionally offer potential
targets that can be harnessed for novel treatment strategies. Hopefully, one day supporting the
development of effective disease-modifying treatments
The Characterization of Alzheimer’s Disease and the Development of Early Detection Paradigms: Insights from Nosology, Biomarkers and Machine Learning
Alzheimer’s Disease (AD) is the only condition in the top ten leading causes of death for which we do not have an effective treatment that prevents, slows, or stops its progression. Our ability to design useful interventions relies on (a) increasing our understanding of the pathological process of AD and (b) improving our ability for its early detection. These goals are impeded by our current reliance on the clinical symptoms of AD for its diagnosis. This characterizations of AD often falsely assumes a unified, underlying AD-specific pathology for similar presentations of dementia that leads to inconsistent diagnoses. It also hinges on postmortem verification, and so is not a helpful method for identifying patients and research subjects in the beginning phases of the pathophysiological process. Instead, a new biomarker-based approach provides a more biological understanding of the disease and can detect pathological changes up to 20 years before the clinical symptoms emerge. Subjects are assigned a profile according to their biomarker measures of amyloidosis (A), tauopathy (T) and neurodegeneration (N) that reflects their underlying pathology in vivo. AD is confirmed as the underlying pathology when subjects have abnormal values of both amyloid and tauopathy biomarkers, and so have a biomarker profile of A+T+(N)- or A+T+(N)+. This new biomarker based characterization of AD can be combined with machine learning techniques in multimodal classification studies to shed light on the elements of the AD pathological process and develop early detection paradigms. A guiding research framework is proposed for the development of reliable, biologically-valid and interpretable multimodal classification models
Regional brain hypometabolism is unrelated to regional amyloid plaque burden
In its original form, the amyloid cascade hypothesis of Alzheimer's disease holds that fibrillar deposits of amyloid are an early, driving force in pathological events leading ultimately to neuronal death. Early clinicopathological investigations highlighted a number of inconsistencies leading to an updated hypothesis in which amyloid plaques give way to amyloid oligomers as the driving force in pathogenesis. Rather than focusing on the inconsistencies, amyloid imaging studies have tended to highlight the overlap between regions that show early amyloid plaque signal on positron emission tomography and that also happen to be affected early in Alzheimer's disease. Recent imaging studies investigating the regional dependency between metabolism and amyloid plaque deposition have arrived at conflicting results, with some showing regional associations and other not. We extracted multimodal neuroimaging data from the Alzheimer's disease neuroimaging database for 227 healthy controls and 434 subjects with mild cognitive impairment. We analysed regional patterns of amyloid deposition, regional glucose metabolism and regional atrophy using florbetapir ((18)F) positron emission tomography, (18)F-fluordeoxyglucose positron emission tomography and T1-weighted magnetic resonance imaging, respectively. Specifically, we derived grey matter density and standardized uptake value ratios for both positron emission tomography tracers in 404 functionally defined regions of interest. We examined the relation between regional glucose metabolism and amyloid plaques using linear models. For each region of interest, correcting for regional grey matter density, age, education and disease status, we tested the association of regional glucose metabolism with (i) cortex-wide florbetapir uptake; (ii) regional (i.e. in the same region of interest) florbetapir uptake; and (iii) regional florbetapir uptake while correcting in addition for cortex-wide florbetapir uptake. P-values for each setting were Bonferroni corrected for 404 tests. Regions showing significant hypometabolism with increasing cortex-wide amyloid burden were classic Alzheimer's disease-related regions: the medial and lateral parietal cortices. The associations between regional amyloid burden and regional metabolism were more heterogeneous: there were significant hypometabolic effects in posterior cingulate, precuneus, and parietal regions but also significant positive associations in bilateral hippocampus and entorhinal cortex. However, after correcting for global amyloid burden, few of the negative associations remained and the number of positive associations increased. Given the wide-spread distribution of amyloid plaques, if the canonical cascade hypothesis were true, we would expect wide-spread, cortical hypometabolism. Instead, cortical hypometabolism appears to be linked to global amyloid burden. Thus we conclude that regional fibrillar amyloid deposition has little to no association with regional hypometabolism
Mental stimulation and multimodal trials to prevent cognitive impairment and Alzheimer ́s disease
Theoretical models of dynamic biomarkers underlying the development of Alzheimer´s
Disease (AD) acknowledge that there is inter-individual variability in the cognitive
performance associated with any level of AD pathology. Mentally stimulating activities
such as schooling, occupation, and leisure activities, may contribute to this variability,
but it is yet unclear how this can be best assessed, and how such effects can vary
across AD severity and among individuals at-risk for cognitive impairment. The
association between mental stimulation and cognitive performance also suggests that it
is important to account for mental stimulation levels in randomized clinical trials (RCTs)
comparing rates of cognitive change between interventions (i.e., drugs, lifestyle
interventions) and controls. The aim of this thesis was to investigate a) how pre-existing
levels of occupational complexity affect the cognitive outcomes of a multimodal
lifestyle-based RCT among older adults at increased risk for dementia based on a
validated risk score b) if occupational complexity is associated to cognitive
performance among individuals at-risk for dementia, including individuals in the early
stages of symptomatic AD (prodromal AD) and c) if occupational complexity is
associated with resilience to AD pathology, measured with validated biomarkers and
neuroimaging among individuals at-risk for cognitive impairment and with prodromal AD.
The four studies in this thesis were based on data from the Finnish Geriatric Intervention
Study to Prevent Cognitive Impairment and Disability (FINGER), the Karolinska University
Hospital electronic database and biobank for clinical research (GEDOC) and The
Multimodal Prevention Trial for Alzheimer´s Disease (MIND-ADmini).
Study I. This study used data from the FINGER study (N=1026) to investigate if preexisting
levels of occupational complexity were associated with cognitive function at
baseline, and if occupational complexity was associated with the rate of change in
cognition during the 2-year intervention period. For all measures of occupational
complexity, higher levels of complexity were associated with better cognitive outcomes
at baseline. Occupational complexity was not associated with the rate of cognitive
change during the intervention, except for the executive function outcome, for which
higher levels of complexity with data predicted increased improvement ((ß[SE]:
.028[.014], p=.044).
Study II. This study used data from the FINGER neuroimaging cohort, to investigate if the
association between occupational complexity and cognition was moderated by
measures of brain integrity, both in terms of magnetic resonance imaging (MRI, N=126)
and Pittsburgh-B Compound – Positron Emission Tomography (PiB-PET, N=41). The
results showed that higher levels of occupational complexity were associated with
better cognitive performance for some outcomes after adjusting for Alzheimer’s Disease
Signature (ADS) and medial temporal atrophy (MTA). However, for most types of
neuropathology and cognitive outcomes, moderation effects indicated that higher
occupational complexity levels were associated with better cognitive performance only
in people with higher brain integrity, suggesting lack of occupational complexity-related
resilience mechanisms.
Study III. This study investigated the association between mental stimulation
(occupational complexity and education) and validated AD biomarkers, Aβ1–42, p-tau
and t-tau measured in cerebrospinal fluid (CSF). Using data from the GEDOC database,
174 individuals with prodromal AD were included, and analyses were adjusted for
cognitive function. The results indicated that both higher occupational complexity and
education were associated with higher levels of p-tau and t-tau. For education the
association with tau pathology was age dependent. No association was found with Aβ1–
42. This suggests that higher education and occupational complexity may provide
resilience against tau-related pathology in prodromal AD.
Study IV. This study used data from FINGER, GEDOC, and MIND-ADmini, thus including a
total of 1410 individuals, 1207 at-risk for dementia and 203 with Prodromal AD. The aim
was to to compare the two most common rating systems for occupational complexity,
the Occupation Information Network (O*NET) and the Dictionary of Occupational Titles
(DOT) and assess if there was an association between occupational complexity and
episodic memory performance among individuals at-risk for dementia. The study found
that higher occupational complexity was only associated with memory performance in
the FINGER cohort but not the two prodromal AD cohorts. The correlation between the
two rating systems was moderate to strong, and highly significant (Spearman’s rho =
0.5-0.6, p <.001).
Conclusions. Higher levels of Occupational complexity are associated with better
cognitive performance among older individuals at-risk for dementia (and with no
substantial cognitive impairment), but does not affect the intervention effect in the
FINGER multidomain lifestyle-based RCT, apart from the effect on executive function.
Occupational complexity does not seem to provide strong resilience against
neuropathology among individuals at-risk for cognitive impairment. Among individuals
with prodromal AD, higher levels of occupational complexity do seem to provide
resilience to tau-related pathology measured with CSF markers but is not associated
with better episodic memory performance. Measuring occupational complexity with the
DOT or O*NET system seems to yield similar results, as the two systems scores are
correlated
The effect of hippocampal function, volume and connectivity on posterior cingulate cortex functioning during episodic memory fMRI in mild cognitive impairment
Objectives: Diminished function of the posterior cingulate cortex (PCC) is a typical finding in early Alzheimer’s disease (AD). It is hypothesized that in early stage AD, PCC functioning relates to or reflects hippocampal dysfunction or atrophy. The aim of this study was to examine the relationship between hippocampus function, volume and structural connectivity, and PCC activation during an episodic memory task-related fMRI study in mild cognitive impairment (MCI). Method: MCI patients (n = 27) underwent episodic memory task-related fMRI, 3D-T1w MRI, 2D T2-FLAIR MRI and diffusion tensor imaging. Stepwise linear regression analysis was performed to examine the relationship between PCC activation and hippocampal activation, hippocampal volume and diffusion measures within the cingulum along the hippocampus. Results: We found a significant relationship between PCC and hippocampus activation during successful episodic memory encoding and correct recognition in MCI patients. We found no relationship between the PCC and structural hippocampal predictors. Conclusions: Our results indicate a relationship between PCC and hippocampus activation during episodic memory engagement in MCI. This may suggest that during episodic memory, functional network deterioration is the most important predictor of PCC functioning in MCI. Key Points: • PCC functioning during episodic memory relates to hippocampal functioning in MCI. • PCC functioning during episodic memory does not relate to hippocampal structure in MCI. • Functional network changes are an important predictor of PCC functioning in MCI
- …